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The role of Foxp3-expressing regulatoryT (Treg) cells in tolerance and autoimmunity is well-
established. However, although of considerable clinical interest, the role ofTreg cells in the
regulation of hematopoietic homeostasis remains poorly understood.Thus, we analysed B
andT lymphopoiesis in the scurfy (Sf) mouse model of Treg cell deﬁciency. In these exper-
iments, the near-complete block of B lymphopoiesis in the BM of adolescent Sf mice was
attributed to autoimmune T cells. We could exclude a constitutive lympho-hematopoietic
defect or a B cell-intrinsic function of Foxp3. Efﬁcient B cell development in the BM early
in ontogeny and pronounced extramedullary B lymphopoietic activity resulted in a periph-
eral pool of mature B cells in adolescent Sf mice. However, marginal zone B and B-1a
cells were absent throughout ontogeny. Developmental B lymphopoietic defects largely
correlated with defective thymopoiesis. Importantly, neonatal adoptive Treg cell therapy
suppressed exacerbated production of inﬂammatory cytokines and restored thymopoiesis
but was ineffective in recovering defective B lymphopoiesis, probably due to a failure
to compensate production of stroma cell-derived IL-7 and CXCL12. Our observations on
autoimmune-mediated incapacitation of the BM environment in Foxp3-deﬁcient mice will
have direct implications for the rational design of BM transplantation protocols for patients
with severe genetic deﬁciencies in functional Foxp3+ Treg cells.
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INTRODUCTION
In mice and humans, B cells are continuously generated through-
out life from self-renewing,hematopoietic stem cells (HSCs). Dur-
ing development, the major anatomical location of hematopoi-
etic activity transits from liver to bone marrow (BM) in late
fetal life. Thus, the BM represents the primary site of B lym-
phopoiesis in the adult (Dorshkind and Montecino-Rodriguez,
2007). During B cell ontogeny, HSC-derived early B cell prog-
enitors undergo a series of highly ordered maturation steps to
ultimately give rise to immature B cells with surface IgM expres-
sion (sIgM; Hardy et al., 2000; Hardy and Hayakawa, 2001). After
exit from the BM, such newly formed sIgM+ B cells continue their
maturation in the spleen to complete development as immuno-
competent mature B cells (Chung et al., 2003). With regard to
surface markers and anatomical location, the overall population
Abbreviations: BAC, bacterial artiﬁcial chromosome; BM, bone marrow; DN,
double-negative; DP, double-positive; HSC, hematopoietic stem cell; IPEX, immun-
odysregulation, polyendocrinopathy, enteropathy, X-linked syndrome; LN, lymph
node; mLN,mesenteric LN; MZ,marginal zone; PECs, peritoneal exudate cells; p.p.,
postpartum; PtC, phosphatidylcholine; scLN, subcutaneous LN; Sf, scurfy; sIgM,
surface IgM; SP, single-positive; TCR, T cell receptor; Treg, regulatory T cell; WT,
wild-type.
of mature B cells in peripheral lymphoid tissues consists of
subpopulations with distinctly different effector functions (All-
man and Pillai, 2008). Recirculating IgMlowIgDhighCD23high
CD21int B-2 cells are located in follicles of spleen and lymphnodes,
whereas non-recirculating IgMhighIgDlowCD23low/–CD21high B
cells are enriched in the splenic marginal zone (MZ). In addi-
tion, IgMhighIgDlowMac-1+ B-1 cells, which can originate from
both fetal and adult B cell developmental pathways (Montecino-
Rodriguez et al., 2006; Tung et al., 2006; Duber et al., 2009; Esplin
et al., 2009), represent the predominant B cell subset in body
cavities, such as the peritoneal cavity.
It has been a longstanding observation that acute and chronic
inﬂammatory immune responses modulate hematopoietic activ-
ity, including central and peripheral B cell development (Naga-
sawa, 2006; Cain et al., 2009). In recent years, considerable
advances have been made in unraveling molecular and cellular
mechanisms of inﬂammatory lympho-hematopoiesis (Nagasawa,
2006; Cain et al., 2009; Trumpp et al., 2010; King and Good-
ell, 2011). Notably, quiescent HSCs have been demonstrated to
respond directly to inﬂammatory cytokines such as IFN-α (Essers
et al., 2009) and IFN-γ (Baldridge et al., 2010) by proliferative acti-
vation. Additional examples of mechanisms that may impinge on
B lymphopoiesis include the redirection of lymphoid progenitor
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differentiation into the myeloid lineage e.g. by Toll-like receptor
stimulation (Nagai et al., 2006), the induction of apoptosis in
early B cell progenitors by the direct action of IFN-γ (Grawunder
et al., 1993; Garvy and Riley, 1994) and resident BM macrophage-
derived type I interferons (Wang et al., 1995), as well as the
mobilization of BM-derived B cell precursors by TNF-α-mediated
modulation of the CXCL12/CXCR4 axis (Nagasawa et al., 1996;
Nagasawa, 2006).
CD4+CD25+ regulatory T (Treg) cells expressing the fork-
head family transcription factor Foxp3 play an indispensable role
in controlling inﬂammatory responses and maintaining immune
homeostasis under physiological conditions (Sakaguchi, 2005;
Sakaguchi et al., 2008). However, a possible role of Treg cells
in maintaining homeostasis of the lympho-hematopoietic sys-
tem remains poorly understood. Scurfy (Sf) mice develop a fatal
multi-organ autoimmune syndrome due to a spontaneous loss-
of-function mutation in the gene encoding Foxp3 and a concomi-
tant genetic deﬁcit of functional Treg cells (Brunkow et al., 2001;
Fontenot et al., 2003). Early studies in this mouse model indi-
cated a decrease in the proportions of splenic B220+ cells that
coincided with an increase of Mac-1+ cells (Clark et al., 1999).
This appeared consistent with systemically elevated GM-CSF lev-
els in Sf mice (Kanangat et al., 1996) and the notion that GM-CSF
administration inhibits B lymphopoiesis in normal mice (Dor-
shkind, 1991). However, the impact of Foxp3+ Treg cell deﬁciency
on lympho-hematopoietic homeostasis, and in particular B lym-
phopoiesis, has only recently begun to be explored further (Chen
et al., 2010; Leonardo et al., 2010; Chang et al., 2012). Studies
during ontogeny of Sf mice revealed progressive hypocellularity
in BM, as compared to Foxp3-proﬁcient mice (Chen et al., 2010).
The concomitant acquisition of an enlarged HSC compartment
with increased proportions of actively dividing cells in the BM
of Sf mice has been associated with altered HSC differentiation
(Chen et al., 2010). Indeed, sustained HSC proliferation is well
known to compromise long-term HSC quality (Passegue et al.,
2005; Wilson et al., 2008). However, the analysis of BM irradiation
chimeras provided ambiguous results with regard to the repopu-
lation capacity of Sf-derived HSCs (Chen et al., 2010; Chang et al.,
2012). Repopulation of lethally irradiated recipient mice with total
BM cells from adolescent Sf mice resulted either in substantially
compromised reconstitution of hematopoietic cells of the T, B,
and myeloid lineages (Chen et al., 2010), or in efﬁcient, although
somewhat delayed reconstitution of the T and B lymphoid com-
partments (Chang et al., 2012). While the reason underlying these
apparent discrepancies among studies is at present still unclear,
an overall defect in HSC function appears inconsistent with the
notion that Sf mice exhibit greatly enhanced myelopoietic activity
(Lee et al., 2009) and increased numbers of myeloid lineage cells
(Lyon et al., 1990; Clark et al., 1999; Brunkow et al., 2001; Lin et al.,
2005).
Interestingly,with regard to B cell development in situ, evidence
was provided that adolescent Sf mice exhibit severe B lymphopoi-
etic defects in the BM (Leonardo et al., 2010; Chang et al., 2012),
coinciding with the virtually complete absence of newly formed B
cells in the spleen (Leonardo et al., 2010). Although it appeared
tempting to speculate that defective lympho-hematopoiesis in
Foxp3-deﬁcient mice is secondary to the development of T
cell-mediated autoimmunity in the absence of functional Treg cells
(Chen et al., 2010; Leonardo et al., 2010; Chang et al., 2012), this
interpretation has not been corroborated by any direct evidence.
Furthermore, these studies did not reveal to what extent B cell
developmental defects observed in the BMof Foxp3-deﬁcientmice
are accompanied by defective T cell development in the thymus.
This appears a particularly relevant question,considering that both
B and T cell developmental pathways are thought to share a com-
mon lymphoid progenitor residing in the BM (Kondo et al., 1997).
Furthermore, it is unknown how the remarkable severity of defec-
tive B cell development in the BM of adolescent Sf mice (Leonardo
et al., 2010;Chang et al., 2012) can be reconciledwith the establish-
ment of a peripheral pool of mature B cells, which is characterized
by recognition of a broad spectrum of self-antigens (Nguyen et al.,
2007; Zhang et al., 2009; Huter et al., 2010; Leonardo et al., 2010)
and increased antibody production with a bias toward IgE as well
as IgG1/IgG2a (Lin et al., 2005). Here, we report on experiments
in the Sf mouse model of Treg cell deﬁciency that were designed to
address these issues.
MATERIALS AND METHODS
MICE
CD45.2 C57BL/6 mice were purchased from Janvier or Taconic.
Congenic CD45.1 C57BL/6 mice and Foxp3-deﬁcient Foxp3ΔEGFP
mice (Lin et al., 2007) were kindly provided by H. von Boehmer
(Dana-Farber Cancer Institute, Boston, MA, USA) and T. Chatila
(The David Geffen School of Medicine, Los Angeles, CA, USA),
respectively. Foxp3-deﬁcient Sf,T cell receptor (TCR)α−/− (Mom-
baerts et al., 1992) and IL-6−/− (Kopf et al., 1994) mice on the
C57BL/6 background, as well as Foxp3 bacterial artiﬁcial chromo-
some (BAC) transgenic mice expressing a Cre recombinase-GFP
fusion protein (Zhou et al., 2008; hereafter referred to as BAC-
Foxp3Cre-GFP) were purchased from the Jackson Laboratory (Bar
Harbor,USA). For some experiments, CD45.1 C57BL/6 mice were
backcrossed to C57BL/6 Foxp3GFP mice (Fontenot et al., 2005),
and Sf mice were backcrossed to TCRα−/− or IL-6−/− mice, as
indicated. Additionally, BAC-Foxp3Cre-GFP mice were backcrossed
to mice, which expressed a Cre recombination reporter allele of
the ubiquitously expressed ROSA26 locus containing a loxP site–
ﬂanked STOP cassette followed by a DNA sequence encoding yel-
lowﬂuorescent protein (YFP;R26-Y; Srinivas et al., 2001) to obtain
BAC-Foxp3Cre-GFP ×R26-Y mice. All mice were housed and bred
at the Experimental Center of the Medizinisch-Theoretisches Zen-
trum (DresdenUniversity of Technology,Germany) under speciﬁc
pathogen-free conditions. Animal experiments were performed as
approved by the Regierungspräsidium Dresden.
FLOW CYTOMETRY AND CELL SORTING
All single cell suspensions were prepared in ﬂuorescent acti-
vated cell sorting (FACS) buffer (1 ×HBSS, 5% FCS, 10 mM
HEPES; all Invitrogen). For this, thymus, spleen, liver, mesen-
teric lymph nodes (mLNs), and a pool of subcutaneous LNs
(scLNs; Lnn. mandibularis, Lnn. cervicales superﬁciales, Lnn. axil-
lares et cubiti, Lnn. inguinales superﬁciales, and Lnn. subiliaci) were
meshed through 70μm cell strainers (BD). BM cells were har-
vested from femurs and tibias by ﬂushing either mechanically
dissociated bones or cavities of intact bones with FACS buffer,
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followed by ﬁltration through 70μm cell strainers. Peritoneal exu-
date cells (PECs) were obtained by peritoneal cavity lavage with
FACS buffer. Single cell suspensions from spleen, liver and BM
were subjected to red blood cell lysis (erythrocyte lysis buffer
EL, Qiagen, Hilden, Germany). Monoclonal antibodies (mAbs)
to B220 (RA3-6B2), CD4 (RM4-5, GK1.5), CD5 (53–7.3), CD8
(53–6.7), CD11c (N418), CD19 (1D3), CD21/CD35 (8D9), CD23
(B3B4),CD25 (PC61),CD45.1 (A20),CD45.2 (104),CD138 (281–
2), c-kit (2B8), GL7 (GL-7), Gr-1 (RB6-8C5), IgD (11–26), IgM
(II/41),Mac-1 (M1/70),NK1.1 (PK136),Ter119 (TER-119),aswell
as APC-, FITC-, Paciﬁc Blue-, PE-, and PerCP-conjugated strepta-
vidin were purchased from eBioscience (Frankfurt, Germany) or
BD (Heidelberg, Germany). Phosphatidylcholine liposomes were
prepared as described (Kretschmer et al., 2003, 2004). Prior to
FACS, for some experiments CD4+ cells were enriched from sin-
gle cell suspensions using biotinylated antibodies directed against
CD4, streptavidin-conjugated microbeads, and the AutoMACS
magnetic separation system (Miltenyi Biotec). Samples were ana-
lyzed on a LSRII or FACSCalibur or sorted using a FACS Aria (all
BD). Data were analyzed using FlowJo software (Tree Star Inc.).
CELL CULTURE
FACS-puriﬁed B220+c-kit+ Pro/Pre-B-I cells from BM were
cultured in IMDM supplemented with 10% FCS (v/v), 1 mM
sodium pyruvate, 1 mM HEPES, 2 mM Glutamax, 100 U/ml
Penicillin-Streptomycin, 0.1 mg/ml Gentamicin, 0.1 mM non-
essential amino acids, and 0.55 mM β mercaptoethanol (all Invit-
rogen). For proliferative expansion (Rolink et al., 1991), 0.5 –
2× 105 cells were co-cultured with 2× 104 ST2 stromal cells in
24-well plates (Greiner) in the presence of home-made recom-
binant murine IL-7 (Hock et al., 1991). For some experiments,
titrating amounts (0.01–100 ng/ml) of recombinant murine IL-2,
IL-4 (both eBioscience), IL-6, IFN-γ (both Peprotech), IL-3, IL-
10, IL-17A, GM-CSF, or TNF-α (all Immunotools) were added, as
indicated. For differentiation into sIgM+ cells, 3× 104 B220+c-
kit+ Pro/Pre-B-I cells that had been isolated by ﬂow cytometry
either from freshly prepared single cell suspensions of BM from
donor mice or from IL-7-supplemented Pro/Pre-B-I cell cultures,
were seeded in 96-well round-bottom plates (Greiner) in the
absence of stromal cells and exogenous IL-7.
ADOPTIVE CELL TRANSFER
IgM+ cells were FACS-puriﬁed from PECs of CD45.1 C57BL/6
mice and 6× 105 cells were injected i.p. into 2-week-old CD45.2
Sf recipient mice, as indicated. For adoptive T cell transfers,
1− 1.5× 107 CD4 magnetic bead-enriched splenocytes from
CD45.1 C57BL/6 Foxp3GFP donor mice were injected i.p. into
≤7-day-old CD45.2 Sf recipient mice.
ANALYSIS OF SERUM Ig LEVELS
Serum IgE and IgG titers were measured by means of ELISA fol-
lowing standard methods. Plates were coated with rat anti-mouse
IgE (R35-72; BD) or goat anti-mouse IgG (Sigma-Aldrich). Igs
were detected with biotinylated rat anti-mouse IgE (R35-118;
BD) and streptavidin-horseradish peroxidase (BD) or horseradish
peroxidase-conjugated goat anti-mouse IgG (Jackson ImmunoRe-
search Laboratories). For quantiﬁcation, puriﬁed mouse IgE κ
antibody (BD) and commercial serum (Bethyl Laboratories)
were used as a reference. o-Phenylenediamine and H2O2 (both
Sigma-Aldrich) were used as substrate.
GENE EXPRESSION ANALYSIS
Single cell suspensions of thymus, BM, spleen, scLNs, or liver
from individual donor mice were either kept separate or pooled
from three donor mice, as indicated, and used for total RNA
extraction, employing the RNeasy Mini kit and DNase I diges-
tion (Qiagen), and cDNA was synthesized according to the man-
ufacturer’s recommendations (SuperScript II reverse transcrip-
tase; Invitrogen). The QuantiFast SYBR Green PCR kit (Qia-
gen) and a Mastercycler ep realplex thermal cycler (Eppendorf)
were used to analyze cDNA in duplicates. The following primers
were used: HPRT, 5′-GTCAACGGGGGACATAAAAG-3′ and 5′-
AGGGCATATCCAACAAC AAAC3′; IL-2, 5′-CCTGAGCAGGAT
GGAGAATTACA-3′ and 5′-TCCAGAACATGC CGCAGAG-
3′; IL-4, 5′-TGACGGCACAGAGCTATTGATGGGT-3′ and 5′-
TCTCCGT GCATGGCGTCCCTT-3′; IL-6, 5′-TCTCTGCAAGA
GACTTCCATCCAGT-3′ and 5′-AGCCTCCGACTTGTGAAGT
GGT-3′; IL-7, 5′-TCCCGCAGACCATGTTCCATGTTT C-3′ and
5′-TTCAACTTGCGAGCAGCACGA-3′; IL-17A, 5′-CTCTCCA
CCGCAATG AAGACCCTGA-3′ and 5′-GCTGCCTGGCGG
ACAATCGAG-3′; IFN-γ, 5′-GGCTG TTACTGCCACGGCACA-
3′and 5′-CACCATCCTTTTGCCAGTTCCTCC-3′; TNF-α, 5′-
G CCCACGTCGTAGCAAACCACCA-3′ and 5′-ACCTGCCCGG
ACTCCGCAAA-3′; CXCL12, 5′-GCTCTGCATCAGTGACGGT
AAACCA-3′ and5′-TGCCCTTGCATCTCCCACGGA-3′. In addi-
tion, mRNA expression of type 1 interferons was assessed
using the following set of primers: IFN-α4, 5′-CCTGTGTGA
TGCAGGAACC-3′and 5′-TCACCTCCCAGGCACAGA-3′; IFN-
non-α4, 5′-ARSYTGTSTGATGCARCAGGT-3′and 5′-GGWAC
ACAGTGATCCTGTGG-3′; IFN-β, 5′-CTGGCTTCCATCATG
AACAA-3′and 5′-CATTTCCGAATGTTCGTCCT-3′, as previ-
ously described (Lienenklaus et al., 2008).
STATISTICAL ANALYSIS
Statistical signiﬁcance was assessed using 5.0c Prism software
(GraphPad) and the unpaired Student’s t test or one-wayANOVA,
as indicated.
RESULTS
B AND T LYMPHOPOIESIS IN ADOLESCENT MICE WITH Foxp3
DEFICIENCY
We initially focused on the assessment of B and T lymphopoi-
etic activity in adolescent Sf mice. In this context, it is important
to note that all Sf mice in our colony housed under speciﬁc
pathogen-free conditions develop external signs of severe autoim-
mune disease (general failure to thrive, exfoliative dermatitis, etc.)
by 4 weeks of age (data not shown), with a median survival of
27 days (see also Figure 5A). Flow cytometric analysis of mori-
bund 4-week-old Sf mice revealed an up to 10-fold reduction in
both percentages and numbers of early B220+c-kit+ Pro/Pre-B-I
cells (nomenclature according to Rolink et al., 1999), as compared
to age-matched wild-type (WT) control animals (Figure 1A, left).
In WT mice, developmental progression of Pre-B-I cells gives rise
to a pronounced compartment of B220+CD25+ Pre-B-II cells,
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FIGURE 1 | Severe B andT lymphopoietic defects in adolescent Sf mice.
B cell compartments in the BM and peripheral lymphoid organs of
4-week-old Sf mice andWT littermate control animals were analyzed by ﬂow
cytometry. T cell development in the thymus was concomitantly assessed.
(A) Flow cytometry of B220+c-kit+ Pro/Pre-B-I (left), B220+CD25+ Pre-B-II
(middle), as well as immature B220lowsIgM+, and mature/recirculating
B220highsIgM+ B cells (right) from BM ofWT (top) and Sf (bottom) mice.
Graphs depict absolute numbers of respective B cell developmental
compartments inWT (blue circles) and Sf (red squares) mice, as indicated.
(B) Correlation of severely reduced Pro/Pre-B-I cell compartments in the BM
(left) of individual Sf mice (Sf #1–3) withT lymphopoietic activity (right) in the
thymus (THY). (C,D) Analysis of peripheral B cell compartments. (C) Flow
cytometry of newly formed IgDlowIgMhigh and mature IgDhighIgMlow B cells in
the spleen. (D) Percentages (histograms) and numbers (graphs) of CD19+ B
cells in spleen (SPL), mLNs, and scLNs. Numbers in dot plots and
histograms indicate the percentage of gated cells within the respective
gates. (E) Percentages of CD138+ plasma cells among B220+ (left) and
B220− (right) B cells in peripheral lymphoid tissues of 4-week-old Sf andWT
mice, as indicated. Dots and horizontal lines in graphs indicate individual
mice and mean values, respectively, and numbers indicate the fold
difference in cell numbers observed inWT (blue circles) and Sf (red squares)
mice. Data are representative of at least two independent experiments
using three to six mice per group. (Student’s t test: ***p ≤0.001;
**p ≤0.01; *p ≤0.05; ns: not signiﬁcant).
which ultimately generate substantial populations of immature
B220lowsIgM+ B cells (Figure 1A, top). In contrast, in Sf mice,
regardless of the existence of a clearly discernable, albeit dramati-
cally reduced population of Pro/Pre-B-I cells, subsequent Pre-B-II
and immature sIgM+ B cell stages were consistently found to be
below the level of detection (Figure 1A,middle and right). Similar
results were obtained with adolescent Foxp3ΔEGFP mice (data not
shown) that lack functional Treg cells due to a targeted insertion
of GFP-encoding sequence into the Foxp3 locus, resulting in the
expression of a non-functional Foxp3 protein fused to GFP (Lin
et al., 2007). Overall, these data are largely consistent with previ-
ous reports (Leonardo et al., 2010; Chang et al., 2012) in that B
cell development in the BM of adolescent Foxp3-deﬁcient mice is
severely abrogated.
Next, we sought to correlate abrogated B lymphopoietic activ-
ity in the BM of Sf mice with T cell development in the
thymus. Thymic aberrations previously reported for Foxp3-
deﬁcient mice include a decrease in thymic cellularity and the
proportion of CD4+CD8+ double-positive (DP) cells (Chang
et al., 2005; Liston et al., 2007). Proportions of CD4−CD8−
double-negative (DN), CD4−CD8+ single-positive (CD8SP), and
CD4+CD8− SP (CD4SP) cells were only moderately increased
in approximately 2-week-old Sf mice (Chang et al., 2005).
Here, we found that B lymphopoietic defects in 4-week-old
Sf mice closely correlated with thymic atrophy. Impairment
of T cell development varied over a broad range of severity
(Figure 1B, Sf #1–3; see also Figure 3D for cell numbers).
Thus, despite severely defective B lymphopoiesis, thymopoietic
aberrations in individual Sf mice ranged from a somewhat per-
turbed distribution of DP and SP thymocyte compartments
(Figure 1B, Sf #1) to substantially abrogated T lymphopoietic
activity, as reﬂected by the nearly complete absence of DP cells
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and concomitantly increased proportions of DN and SP cells
(Figure 1B, Sf #3).
After exit from the BM, maturation of B cells continues in the
periphery (Chung et al., 2003). Consistent with severely reduced
numbers of immature B220lowsIgM+ B cell in the BM (Figure 1A,
right), the population of newly formed IgDlowIgMhigh B cells in the
spleen was substantially reduced in Sf mice (0.6 ± 0.4× 106 cells),
as compared to age-matched WT control animals (4.4± 1.4× 106
cells; Figure 1C). Consequently, splenic B cell numbers with a
mature IgDhighIgMlow phenotype were drastically reduced (Sf:
3.0± 2.2× 106 cells; WT: 16.6± 3.1× 106 cells; and Figure 1C).
This reduction in B cell numbers was restricted to the spleen
(Figure 1D). In LNs, proportions of CD19+ B cells were largely
comparable in Sf mice with pronounced lymphadenopathy and
healthy WT mice (Figure 1D, histograms). Numbers of CD19+
cells were >20-fold increased in scLNs of Sf mice (Figure 1D,
graph). Thus, despite severely abrogated central and peripheral
B cell development, which at least partly correlated with defec-
tive thymopoiesis, 4-week-old Sf mice exhibit sizable populations
of mature B cells in peripheral lymphoid organs. Notwithstand-
ing previously reported severe hyperimmunoglobulinemia E and
elevated IgG1 and IgG2a serum levels (Lin et al., 2005), pro-
portions of B cells with an antibody-secreting B220+/−CD138+
plasma cell phenotype in spleen and LNs of adolescent Sf mice
appeared somewhat reduced, as compared to WT control mice
(Figure 1E).
MECHANISMS OF DEFECTIVE B LYMPHOPOIESIS
Previous studies employing mice with Foxp3-dependent ﬂuo-
rochrome reporter activity indicated that high levels of Foxp3
expression are limited to αβ T cells (Fontenot et al., 2005; Wan
and Flavell, 2005), with undetectable ﬂuorochrome expression in
B220+ cells from BM (Leonardo et al., 2010) and secondary lym-
phoid organs such as LNs (Wan and Flavell, 2005) and spleen
(Leonardo et al., 2010). Whether Foxp3 can be expressed in other
hematopoietic (Bernard et al., 2009; Manrique et al., 2011) and
non-hematopoietic (Chang et al., 2005; Hinz et al., 2007; Zuo
et al., 2007; Chen et al., 2008; Karanikas et al., 2008; Chung
et al., 2010) lineages has been actively debated (Liston et al.,
2007; Mayer et al., 2012). To formally exclude the possibility that
observed alterations in B cell development of Sf mice are due to a
B cell-intrinsic function of Foxp3, we tracked B cells in peripheral
lymphoid organs of BAC-Foxp3Cre-GFP ×R26-Y mice that exhibit
YFP expression in cells only after Foxp3-dependent Cre recom-
binase activity and resultant excision of a loxP-ﬂanked STOP
cassette (Zhou et al., 2008). Flow cytometric analysis revealed a
minute population of CD19+ B cells (≤0.1%) in spleen and LNs of
BAC-Foxp3Cre-GFP ×R26-Y mice that appeared to co-express YFP
(Figure 2A, left). However, post-sort analysis of FACS-puriﬁed
cells established that this putative CD19+YFP+ population mainly
consisted of doublets of CD19+YFP− and CD19−YFP+ cells,
demonstrating that the potential population size of CD19+ cells
that are trulyYFP+ is negligible (spleen:≤0.003%; LNs:≤0.008%;
Figure 2A, right).
Consistent with the lack of a B cell-intrinsic function of
Foxp3, our analysis of differentiation of B cell precursors in vitro
in the absence of IL-7 (Rolink et al., 1991; Kretschmer et al.,
2002) showed that FACS-puriﬁed populations of initially sIgM−
Pro/Pre-B-I cells (B220+c-kit+) frommoribundSf mice efﬁciently
differentiated into sIgM+ cells albeitwith somewhat delayed kinet-
ics, as compared to cells from WT controls (Figure 2B, left). This
subtle delay in efﬁciency of in vitro differentiation of Pro/Pre-
B-I cells from Sf mice was mitigated when sIgM− Pro/Pre-B-I
cells were expanded in IL-7-supplemented cultures prior to IL-7
deprivation to initiate differentiation into sIgM+ cells (Figure 2B,
right).
To directly assess the impact of T cell-mediated autoimmu-
nity on defective B lymphopoietic homeostasis in the absence
of functional Treg cells, we next analyzed B cell developmental
compartments in Sf mice that were deﬁcient in the major αβ
T cell population due to lack of TCRα chain (Sf ×TCRα−/−).
As expected from earlier studies in athymic nude mice on the Sf
background (Godfrey et al., 1991), Sf ×TCRα−/− mice were pro-
tected from severe autoimmune pathology and premature death
in the absence of CD4+ and CD8+ T cells (data not shown).
Furthermore, B cell developmental compartments in the BM of
Sf ×TCRα−/− mice were found to be comparable with Foxp3-
proﬁcient TCRα−/− mice, as judged by proportions of Pro/Pre-
B-I, Pre-B-II, and immature B cells (Figure 2C). Thus, αβ T cells
play a dominant role in autoimmune-mediated abrogation of B
cell development in the BM of Sf mice.
In comparison to WT mice, adolescent Sf mice exhibit largely
elevated levels of various inﬂammatory cytokines like IL-6, IL-
17, and IFN-γ that circulate in the blood (Lin et al., 2005; Zhang
et al., 2009; Haribhai et al., 2011). The comparative analysis of
adolescent Sf mice that were either proﬁcient or deﬁcient in IL-6
revealed a dispensable role of IL-6 and thus IL-6-dependent differ-
entiation of IL-17-producing T effector cells (Bettelli et al., 2006)
in mediating external signs of autoimmune-mediated morbidity
(data not shown) and defective B lymphopoiesis (Figure 2D). This
observation was further corroborated by in vivo administration of
neutralizing mAbs to IL-6 (data not shown).
The addition of graded amounts of recombinant IL-6 (data not
shown) or IL-17A (Figure 2E, left) to cultures of FACS-puriﬁed
populations of B220+c-kit+ Pro/Pre-B-I cells from WT mice did
also not appreciably impinge on IL-7-dependent proliferation and
survival of B cell precursors. Similar results were obtained with
IL-2, IL-3, IL-4, IL-10, GM-CSF, and TNF-α (data not shown).
However, in agreement with previous observations (Grawunder
et al., 1993;Garvy andRiley,1994), IFN-γ abrogated the survival of
Pro/Pre-B-I cells in vitro in a dose-dependent manner (Figure 2E,
right). In vivo, long-term administration of neutralizing mAbs to
IFN-γ was found to have no appreciable beneﬁcial effect on both
defective B lymphopoiesis and premature death of Sf mice (data
not shown), suggesting a redundant function of IFN-γ in vivo,
possibly due to the compensatory action of other inﬂammatory
cytokines.
We next assessed the in situ production of inﬂammatory
cytokines by quantitative RT-PCR using total RNA extracted
from whole tissues of adolescent Sf and WT control animals.
These experiments conﬁrmed increased expression levels of var-
ious inﬂammatory cytokines in spleen, LNs, and liver of Sf mice
(Zhang et al., 2009), with exacerbated production of IL-6 and IL-
17 being mainly restricted to the liver (Figure 2F). The expression
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FIGURE 2 | Mechanisms of B cell developmental defects in adolescent
Sf mice. (A) Genetic lineage tracing of Foxp3 reporter activity in peripheral
B cells. Putative populations of CD19+YFP+ cells were FACS-puriﬁed from
spleen (top) and pooled mLNs and scLNs (bottom) of adult
BAC-Foxp3Cre-GFP ×R26-Y mice. Flow cytometric presort analysis (left) and
post-sort analysis (right) is depicted. Note that for presort analysis numbers
in dot plots indicate percentages of cells within the respective gates,
whereas for post-sort analysis numbers indicate percentages of
CD19+YFP+ cells among total cell populations prior to FACS puriﬁcation. (B)
Differentiation capacity of Pro/Pre-B-I cells from moribund Sf mice in vitro.
Initially sIgM−, B220+c-kit+ Pro/Pre-B-I cells, either freshly isolated from
BM of 3-week-oldWT (blue circles) or Sf (red squares) mice (left), or
isolated from IL-7-supplemented cultures after proliferative expansion of
respective Pro/Pre-B-I cell populations (right), were cultured in the absence
of added IL-7. The capacity to differentiate into sIgM+ cells was assessed at
different time points after initiation of cultures, as indicated. Symbols
represent mean values of replicate wells ± SEM. (C) B cell development in
Sf mice that lack CD4+ and CD8+ T cells. Flow cytometry of indicated B cell
developmental stages in the BM of 4-week-oldWT (top) and Sf (bottom)
mice that additionally lackedTcra gene expression (TCRα−/−). Numbers in
dot plots indicate the percentage of cells in the respective gate. Data are
representative of three independent experiments. (D) Flow cytometric
analysis of immature B220lowsIgM+ and mature/recirculating B220highsIgM+
B cell compartments in the BM of 4-week-old Sf mice that were either
proﬁcient (IL-6+/−, top) or deﬁcient (IL-6−/−, bottom) for IL-6. Numbers in dot
plots indicate the percentage of cells in the respective gate. Data are
representative of two independent experiments. (E) Impact of
inﬂammatory cytokines on IL-7-mediated survival of Pro/Pre-B-I cells in vitro.
FACS-puriﬁed populations of BM-derived B220+c-kit+ Pro/Pre-B-I cells from
WT mice were cultured with IL-7, either alone or in the presence of titrating
amounts of IL-17A or IFN-γ, as indicated. At day 4 of cultures, numbers of
B220+c-kit+ cells recovered from cultures with and without added
inﬂammatory cytokines was calculated as fold difference. Shown are mean
and range of duplicate wells. Data are representative of two independent
experiments. (F,G)The expression of mRNAs encoding (F) indicated
inﬂammatory cytokines and (G) IL-7 and CXCL12 was assessed by
quantitative RT-PCR employing whole tissues harvested from 4-week-old
WT (blue) or Sf (red) mice, as indicated. Note that, prior to RNA extraction,
prepared single cell suspensions of respective tissues were pooled from
three mice per group. HPRT was used for normalization. Shown are mean
and range of duplicate samples. Data are representative of at least three
independent experiments.
of type 1 interferons (IFN-α4, IFN-non-α4, and IFN-β) was found
to be moderately increased in liver and LNs of Sf mice (Figure 2F,
bottom). In primary lymphoid organs, substantially increased
expression levels of IL-2, IL-4, and IFN-γ were found in thymus,
whereas inﬂammatory cytokine expression appeared negligible in
BM (Figure 2F).
We then extended our expression analysis to factors with well-
established functions in promoting lympho-hematopoiesis and B
cell development. It became clear that mRNA expression levels
of IL-7 and CXCL12 were consistently decreased in the BM of
adolescent Sf mice, as compared to WT control mice (Figure 2G).
Thus, exacerbated production of IFN-γ in peripheral lymphoid
tissues, as well as decreased expression of IL-7 and CXCL12 in situ
may represent non-mutually exclusive mechanisms that negatively
impinge on developmental homeostasis of B cells in the BM of
Sf mice.
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ORIGIN OF MATURE B CELLS IN THE PERIPHERY OF ADOLESCENT Sf
MICE
Adolescent Sf mice exhibit sizable populations of mature B cells
in their LNs (Figure 1D). How can the existence of these cells
be reconciled with severely abrogated central and peripheral B cell
development? Initial BrdUpulse-chase experiments indicated that,
in comparison to WT control animals, adolescent Sf mice exhibit
moderately increased frequencies (≤2-fold) of cycling BrdU+ cells
among peripheral CD19+ B cells (data not shown). This observa-
tion raises the possibility that hyperproliferation (e.g., driven by
lymphopenia) of B cells, which might originate from minimal B
lymphopoietic activity in the BM,may at least partly contribute to
the establishment and maintenance of the mature pool of periph-
eral B cells in adolescent Sf mice. In addition, we addressed the
hypothesis that Sf mice might be permissive to efﬁcient B cell pro-
duction, prior to the manifestation of autoimmune-mediated B
cell developmental defects in the BM. To this end, we performed
a comparative temporal analysis of B cell development during
ontogeny of Sf and WT mice (Figures 3A,B).
Due to postnatal B lymphopoietic activity, residual numbers
of early B220+c-kit+ Pro/Pre-B-I cells remained detectable in
the liver of WT mice until day 7 postpartum (p.p.), but rapidly
declined thereafter (Figure 3A, left). This resulted in an over-
all decrease of the subsequent Pre-B-II and immature sIgM+ B
cell stages below the level of detection within the third week after
birth (Figure 3A,middle and right). Cessation of B lymphopoietic
activity in the postnatal liver (Figure 3A) coincided with gradu-
ally increasing proportions andnumbers of Pro/Pre-B-I cells in the
BM until the second week p.p. and then apparently reached steady
state (Figure 3B, left). The subsequent B220+CD25+ Pre-B-II and
immature sIgM+ B cell compartments in BM still continued to
increase in size during the observation period (Figure 3B, middle
and right).
In striking contrast, Sf mice exhibited aberrantly prolonged
and enhanced extramedullary B lymphopoietic activity in the liver
(Figure 3A) and spleen (Figure 3C), as indicated by Pro/Pre-B-I,
Pre-B-II and immature B cell compartments that continued to
markedly increase in size after day 7 p.p. (Figure 3A and data not
shown).
Notably, until day 7 p.p., the population size of B cell devel-
opmental compartments in the BM was essentially comparable
between Sf and WT littermate control animals (Figure 3B). How-
ever, severe B cell developmental aberrations became obvious
within the second week after birth. This included a substan-
tially increased compartment of CD19-expressing B220+c-kit+
Pro/Pre-B-I cells (Figure 3B, left). Importantly, after day 7 p.p., the
population size of all subsequent B cell developmental stages in the
BM never reached WT levels (Figure 3B, middle and right), most
likely due to impairment in developmental progression and/or
imparted proliferative expansion and survival of Pre-B-I/-II cells.
In any case,medullary and extramedullary B lymphopoietic activ-
ity in Sf mice appeared sufﬁcient to produce signiﬁcant numbers
of immature sIgM+ B cells that peaked within the third week p.p.
but dropped below the level of detection thereafter (Figures 3A,B,
right).
In contrast to our observation of early B lymphopoietic aberra-
tions in liver, spleen, and BM (Figures 3A,B) and previous reports
on thymopoietic aberrations in Sf mice as early as day 7 p.p. (Chang
et al., 2005), our concomitant temporal analysis of T cell develop-
ment during ontogeny of Sf mice revealed normal cellularity of the
thymus and thymocyte populations until day 14 p.p. (Figure 3D,
and data not shown). Subsequent manifestation of thymic atro-
phy and abrogated T cell development exempliﬁed by substantially
reduced proportions of DP thymocytes (Figure 3D, right; see also
Figure 1B), appeared to correlate with progressive autoimmune
pathology of Sf mice.
PERIPHERAL B CELL MATURATION DURING ONTOGENY OF Sf MICE
In the spleen of Sf mice, we found numbers of newly formed
IgDlowIgMhigh B cells to be reduced as early as day 7 p.p., as
compared to WT littermate control mice (Figure 4A, left). While
the compartment size of mature IgDhighIgMlow B cells failed to
reach WT levels during ontogenetic progression, signiﬁcant num-
bers of CD19+ B cells were maintained until Sf mice succumbed
to autoimmune pathology (Figure 4A, middle and right). Thus,
reduced splenic B cell maturation in Sf mice is likely to be a conse-
quence of ceasing central B lymphopoiesis and abrogated export
of immature sIgM+ B cells to the spleen.
During normal mouse ontogeny,maturation of the splenic MZ
B cell compartment (Figure 4B) is delayed relative to the appear-
ance of conventional B cells (Figure 4A) and coincides with the
temporally regulated maturation of the microarchitecture of the
MZ until about 3–4 weeks after birth (Pillai et al., 2005). Whereas
inWT mice, splenic IgMhighIgDlowCD23low/−CD21high MZ B cells
became ﬁrst apparent at day 14 p.p., Sf mice exhibited a complete
lack of this B cell subset throughout life (Figure 4B), probably due
to autoimmune-mediated alterations in splenic architecture.
In the peritoneal cavity of Sf mice, the reduction of IgM+ B
cell numbers after day 14 p.p. (Figure 4C, left) could be attrib-
uted to a selective and nearly complete lack of CD5+ B-1a cells
(IgMhighIgDlowMac-1+) throughout ontogeny (Figure 4C).Num-
bers of CD5− B cells, which comprise the B-1b sister popula-
tion (IgMhighIgDlowMac-1+) as well as conventional B-2 cells
(IgMlowIgDhighMac-1−), were comparable between Sf and WT
littermate control mice (Figure 4C, and data not shown). This
marked and selective reduction of peritoneal CD5+IgMhigh B-
1a cells throughout life of Sf mice was unexpected, considering
that B-1a cells can originate from both fetal and adult B cell
developmental pathways (Montecino-Rodriguez et al., 2006; Tung
et al., 2006; Duber et al., 2009; Esplin et al., 2009). To exclude
the possibility that our failure to detect signiﬁcant populations
of CD5+IgMhigh B-1a cells in the peritoneal cavity of Sf mice
was due to the mere down-regulation of CD5 expression in an
autoimmune environment, we additionally tracked peritoneal B
cells whose B cell receptor is reactive to phosphatidylcholine (PtC).
PtC represents a well-documented speciﬁcity to common bacterial
and autoantigens that, in normal mice, is restricted to B-1a cells
(Baumgarth et al., 2000; Kretschmer et al., 2003, 2004). Our results
showed that proportions and numbers of PtC-speciﬁc cells among
totalCD19+ Bcells aswell as residualCD5+IgMhigh B-1a cellswere
markedly decreased in 3–4-week-old Sf mice, as compared to WT
littermate controls (Figure 4D).
In addition, we asked whether the autoimmune environment
in Sf mice might hamper peritoneal retention and/or survival of
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FIGURE 3 |Temporal analysis of lymphopoiesis during ontogeny of Sf
mice. B andT lymphopoiesis was analyzed by ﬂow cytometry in newborn
pups and at different time points after birth (day 2, 7, 9, 12, 14, 17, 20, 24, and
28). (A) B lymphopoiesis in the liver. Representative ﬂow cytometry of
B220+c-kit+ Pro/Pre-B-I (left), B220+CD25+ Pre-B-II (middle), as well as
immature B220lowsIgM+ and mature/recirculating B220highsIgM+ (right) cells
from liver of 17-day-oldWT (top) and Sf (bottom) mice. Graphs depict absolute
numbers of respective B cell developmental compartments inWT (blue
circles) and Sf (red squares) mice, at indicated time points during ontogeny.
(B) B lymphopoiesis in the BM. Representative ﬂow cytometry of B cell
development in the BM of 7-day-oldWT and Sf mice. CD19 expression on
gated B220+c-kit+ Pro/Pre-B-I cells from BM of 17-day-old Sf mice is shown as
inserted histograms (left). Graphs depict absolute numbers of respective B
cell developmental compartments. (C) Absolute numbers of indicated B cell
developmental stages in BM, spleen (SPL), and liver (Liv) of 16-day-oldWT
(blue circles) and Sf (red squares) mice. Symbols and lines in graphs indicate
individual mice and mean values, respectively. (D)Thymic cellularity (left) and
proportions of DP thymocytes (right). Numbers in dot plots and histograms
indicate the percentages of gated cells within the respective gates. Symbols
and lines in graphs indicate individual mice and mean values, respectively.
Data were collected from independent experiments using a minimum of
three individual mice per age group and strain, as indicated.
B-1a cells. To this end, congenically marked IgM+ B cells that
had been FACS-puriﬁed from PECs of CD45.1+ WT donor mice
were adoptively transferred i.p. into 2-week-old CD45.2+ WT or
Sf recipient mice, exhibiting early external signs of autoimmune
pathology (data not shown). Flow cytometric analysis of Sf recip-
ient mice, which had to be sacriﬁced 2 weeks after injection due
to severe autoimmune symptoms, conﬁrmed that the population
of endogenous CD45.1−CD45.2+ B-1a cells was greatly reduced,
as compared to WT recipient mice (Figure 4E, left). In contrast,
adoptively transferred CD45.1+CD45.2− B-1a cells were main-
tained in the peritoneal cavity of Sf mice until the end of the
observation period (Figure 4E, right). These ﬁndings suggest that
the severe and selective reduction of the peritoneal B-1a compart-
ment in Sf mice is due to aberrations in development, migration
and recruitment of CD5+IgMhigh B-1a cells, rather than due to
abrogated retention and survival signals.
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FIGURE 4 |Temporal analysis of peripheral B cell compartments during
ontogeny of Sf mice. Cohorts of experimental Sf andWT mice described in
Figure 3 were concomitantly employed for the analysis of peripheral B cell
compartments. (A) Peripheral B cell maturation in the spleen.
Representative ﬂow cytometry of newly formed IgDlowIgMhigh and mature
IgDhighIgMlow B cells (dot plots), as well as CD19+ B cells (histograms) in the
spleen of 7-day-oldWT (top) and Sf (bottom) mice. Graphs depict absolute
numbers of respective B cell compartments fromWT (blue circles) and Sf
(red squares) mice, at indicated time points during ontogeny. (B)
IgMhighIgDlow CD23low/−CD21high MZ B cells. Representative ﬂow cytometry
of IgMhighCD21high MZ B cells among gated IgDlowCD23low/− splenocytes of
4-week-old mice (top), and absolute numbers of MZ B cells during ontogeny
ofWT and Sf mice (bottom). (C) B cell subsets in the peritoneal cavity.
Representative ﬂow cytometry of IgM, IgD, and CD5 expression among
PECs from 4-week-old mice, as well as absolute numbers of peritoneal B
cell subsets (B-2: IgDhighIgMlow; B-1: IgDlowIgMhigh; B-1a:
IgMhighIgDlowCD5+Mac-1+; B-1b: IgMhighIgDlowCD5−Mac-1+). (D) Flow
cytometry of PtC-reactive B cells among gated populations of total CD19+
(left panels) and CD19+CD5+ (right panels) PECs from 3–4-week-oldWT
(n=7) and Sf (n=5) mice, as indicated. (E)Total populations of sIgM+ cells
were FACS-puriﬁed from PECs of CD45.1+ WT mice and adoptively
transferred i.p. into 2-week-old CD45.2+ WT (n=3) and Sf (n=3) recipient
mice, as indicated. 14 days after cell transfer, recovered PECs were analyzed
for the expression of sIgM and CD5 among gated endogenous CD45.2+
cells (left) or CD45.1+ donor cells (right). Data are representative of two
independent experiments. Numbers in dot plots and histograms without
parentheses indicate the percentage (A–C) and mean percentages ± SEM
(D,E) of gated cells within the respective gates. Parenthesized numbers
indicate mean absolute numbers (× 103 ±SEM) of PtC+ cells (D). Symbols
and lines in graphs indicate individual mice and mean values, respectively.
IMPACT OF ADOPTIVE Treg CELL THERAPY ON DEFECTIVE B AND T
LYMPHOPOIESIS
Neonatal adoptive transfer of puriﬁed populations of
CD4+CD25+Foxp3+ Treg cells ameliorates exacerbated immune
cell activation (Fontenot et al., 2003) and prolongs survival of
Foxp3-deﬁcient recipient mice (Smyk-Pearson et al., 2003). Inter-
estingly, adoptively transferred bulk populations of CD4+ T cells
that include functional Foxp3+ Treg cells have been demonstrated
to be far more effective in the suppression of chronic autoim-
mune inﬂammation (Smyk-Pearson et al., 2003;Chang et al., 2008;
Haribhai et al., 2011). In these studies, the impact of adoptive Treg
cell therapy on the establishment of severe lympho-hematopoietic
defects in Foxp3-deﬁcient mice had not been addressed. To assess
the impact of functional Foxp3+ Treg cells on the develop-
ment of defective B and T lymphopoiesis during ontogeny of
Sf mice, we injected magnetic bead-enriched bulk populations
of CD4+CD45.1+ T cells from peripheral lymphoid organs of
Foxp3GFP mice into CD45.2+ Sf mice within the ﬁrst week after
birth.
As expected (Smyk-Pearson et al., 2003; Chang et al., 2008;
Haribhai et al., 2011), treated Sf mice consistently exhibited long-
term survival (Figure 5A) and appeared phenotypically healthy
throughout the observation period. Exceptionally, individual Sf
mice displayed mild exfoliative dermatitis restricted to the tail
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FIGURE 5 | AdoptiveTregcell transfer in Sf mice. (A) Kaplan-Meier survival
curves of CD45.2 Sf mice that had either been left untreated (red squares;
n=14) or injected with total populations of CD4+ T cells from Foxp3-proﬁcient
CD45.1+ Foxp3GFP mice (green triangles; n=11), as indicated by the arrow.
6–8weeks after cell transfer, recipient Sf mice were subjected to analysis by
ﬂow cytometry and RT-PCR. Data were collected from 2 (B,C) or 3 (F)
independent experiments. (B,C) Congenically markedT cells were tracked in
primary and secondary lymphoid organs of recipient mice. (B) Absolute
numbers and (C) ﬂow cytometry of CD4+CD45.1+ cells (left) for Foxp3GFP
expression among gated CD4+CD45.1+ cells (right) in indicated organs. Lines
with arrowheads illustrate the gating scheme. Dots and horizontal lines in
graphs indicate individual mice and mean values, respectively. Numbers in dot
plots without parentheses indicate the percentage of gated cells within the
respective gates. Parenthesized numbers indicate mean percentages ± SD of
CD45.1+ cells among gated CD4+ cells (left) or mean percentages ± SD of
Foxp3+ cells among gated CD4+CD45.1+ cells (right). (D,E) Impact of
adoptive Treg cell transfer on in situ production of cytokines. The expression of
mRNAs encoding (D) indicated inﬂammatory cytokines and (E) IL-7 and
CXCL12 was assessed by quantitative RT-PCR employing total RNA extracted
from indicated whole tissues of Sf mice that had previously been injected
with Treg cells. Each dot represents an individual Sf recipient mouse, and
horizontal bars indicate mean values. Bars depict mean values from pooled
single cell suspensions of three individual untreated 4-week-old Sf mice. Blue
hatched lines indicate mRNA expression levels inWT animals for comparison
(see also Figures 2F,G). HPRT was used for normalization. Data are
representative of at least three independent experiments. (F) Impact of
adoptive Treg cell transfer onT cell development in the thymus of Sf mice.
Representative ﬂow cytometry of CD4 and CD8 expression on thymocytes
fromWT mice (6-week-old; top) and Sf mice that were either left untreated
(4-week-old; middle) or treated with adoptive Treg cell transfer (6–8-week-old;
bottom). Numbers in dot plots indicate the percentages of gated cells within
the respective gates. Graphs depict total thymic cellularity (top), as well as
percentages (middle) and numbers (bottom) of DP thymocytes ofWT mice
(blue circles), as well as Sf mice that were either left untreated (red squares)
or treated with adoptive Treg cell transfer (green triangles). Symbols and
horizontal lines in graphs indicate individual mice and mean values,
respectively. (One-way ANOVA: ***p ≤0.01; **p ≤0.01; *p ≤0.05; ns, not
signiﬁcant).
(data not shown). Flow cytometric analysis at approximately
8 weeks after adoptive transfer revealed the presence of con-
genically marked donor CD4+ T cells in all primary (BM and
thymus) and secondary (spleen, LNs and peritoneal cavity) lym-
phoid organs analyzed (Figures 5B,C). Highest numbers of adop-
tively transferred CD45.1+CD4+ T cells could be recovered from
spleen and LNs (Figure 5B). Interestingly, Foxp3GFP+ Treg cells,
which initially comprised approximately 15% of the adoptively
transferred CD45.1+CD4+ T cell population (data not shown),
preferentially accumulated in lymphoid organs of Sf recipient
mice, as compared to Foxp3GFP−CD4+ T cells (Figure 5C). This
selective enrichment was most pronounced in the BM, with up to
90% of CD45.1+CD4+ T cells expressing Foxp3GFP (Figure 5C).
RT-PCR-basedmRNAquantiﬁcationof inﬂammatory cytokine
expression revealed that adoptively transferred Treg cells effectively
suppressed production of IL-4, IL-6, and IL-17 but, unexpect-
edly, failed to prevent exacerbated production of IFN-γ in primary
and secondary lymphoid organs of Sf recipient mice (Figure 5D;
see also Figure 2F for comparison). Furthermore, it appeared
that individual Sf recipient mice exhibited somewhat increased
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expression levels of type 1 interferons selectively in the liver (IFN-
α4, Figure 5D; IFN-non-α4 and IFN-β, data not shown). In addi-
tion, adoptively transferred Treg cells failed to effectively restore
expression of IL-7 and CXCL12 in the BM of Sf mice (Figure 5E;
see also Figure 2G for comparison).
At approximately 8 weeks of age, total thymic cellularity and the
proportional distribution of T cell developmental stages in the thy-
mus of the vastmajority of treated Sf micewere largely comparable
to age-matched WT control animals (Figure 5F). Consistent with
partially rescued IL-7 production in the BM of individual Sf recip-
ient mice (Figure 5E), concomitant analysis of B cell development
in the BM revealed that the size of the B220+c-kit+ Pro/Pre-B-I
cell compartment was greatly increased in Sf mice that had been
treated with WT CD4+ T cells, as compared to untreated, 3- to
4-week-old Sf mice (Figure 6A, left; see also Figures 1A and 3B).
However, developmental progression to the Pre-B-II cell stage
remained substantially impaired in treated Sf mice (Figure 6A,
middle). Minimal production of BM-derived immature sIgM+ B
cells (Figure 6A, right) correlated with a considerably reduced
splenic compartment of newly formed IgDlowIgMhigh B cells,
as compared to age-matched WT animals (Figure 6B). Despite
inefﬁcient central and peripheral B lymphopoiesis in treated Sf
mice, neonatal Treg cell transfer resulted in the accumulation of
robust populations of mature IgDhighIgMlow B cells in periph-
eral lymphoid tissues (Figure 6B), with substantially reduced
proportions of B cells expressing the activation/germinal center
B cell marker GL7 (Figure 6C, left panel). Consistently, neona-
tal Treg cell transfer efﬁciently prevented the manifestation of
FIGURE 6 | Impact of adoptiveTregcell transfer on B cell development in
Sf mice. Central and peripheral B cell compartments were analyzed in
cohorts of experimental mice described in Figure 5. (A) B cell development in
the BM. Representative ﬂow cytometry of B220+c-kit+ Pro/Pre-B-I (left),
B220+CD25+ Pre-B-II (middle), as well as immature B220lowsIgM+ and
mature/recirculating B220highsIgM+ (right) cells from BM ofWT (top) and Sf
mice that were either left untreated (middle) or treated with adoptive Foxp3+
Treg cell transfer (bottom). Graphs depict percentages of respective B cell
developmental compartments fromWT (blue circles), as well as untreated
(red squares) and treated Sf (green triangles) mice. (B) B cell compartments
in the spleen. Representative dot plots of newly formed IgDlowIgMhigh and
mature IgDhighIgMlow B cells in mice as in (A), and graphs depicting the ratio of
mature and newly formed B cells (top) and absolute numbers of IgMhighIgDlow
CD23low/−CD21high MZ B cells (bottom). (C) Percentages of LN-derived B220+
cells expressing the activation/germinal center B cell marker GL7, as revealed
by ﬂow cytometry (left), and quantiﬁcation of IgE and total IgG levels (μg/ml)
in serum (middle and right) fromWT (blue circles) and untreated Sf (red
squares) mice (both 4-week-old), as well as treated Sf (green triangles) mice
(>4–7-month-old). (D) Representative ﬂow cytometry of IgM and CD5
expression among PECs from mice as in (A), and graphs depicting absolute
numbers of total IgM+ cells (top) and IgMhighCD5+ B-1a cells (bottom). (E)
Representative ﬂow cytometry of IgMhighCD21high MZ B cells among gated
IgDlowCD23low/− splenocytes (left) and peritoneal IgMhighCD5+ B-1a cells (right)
in four-week-old Sf×TCRα+/− and Sf×TCRα−/− mice, as indicated. Numbers in
dot plots indicate the percentage of gated cells within the respective gates.
Dots and horizontal lines in graphs indicate individual mice and mean values,
respectively. For experimental details see also legend to Figure 5. (One-way
ANOVA: ***p ≤0.001; *p ≤0.05; ns, not signiﬁcant).
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hyperimmunoglobulinemia E in Sf mice (Figure 6C, middle).
In these experiments, total IgG levels did not vary all that much
betweenWTandmoribund Sf mice (both 4-week-old) andneona-
tally treated Sf mice at the age of >4 months (Figure 6C). Mod-
erately increased IgG levels in treated Sf mice most likely reﬂect
the inevitable accumulation of serum IgGs with aging. Overall,
these data suggest that adoptively transferred Treg cells promote
the accumulation of mature peripheral B cells by suppression
of chronic B cell activation and subsequent differentiation into
plasma cells, thereby counteracting exhaustion of the mature
peripheral B cell pool.
However, adoptive Treg cell therapy of Sf mice was ineffective in
correcting both the absence of splenic MZ B cells (Figure 6B, bot-
tom right) and the severely reduced peritoneal B-1a compartment
(Figure 6D). However, splenic MZ B cells and peritoneal B-1a
cells were readily detectable in Sf ×TCRα−/− mice (Figure 6E)
and in Foxp3-proﬁcient BM irradiation chimeras after reconstitu-
tion with HSCs from Sf mice (data not shown). Thus, it appears
that neonatal adoptive Treg cell therapy for Sf mice is able to pro-
vide long-term survival and thymopoietic homeostasis, but fails
to efﬁciently prevent the severe defects in B lymphopoiesis during
ontogeny of Sf mice.
DISCUSSION
In this study, we have shown that the virtually complete block
of B lymphopoiesis in the BM of adolescent Sf mice (Figure 1A;
Leonardo et al., 2010; Chang et al., 2012) is based on the grad-
ual acquisition of B cell developmental defects during mouse
ontogeny, rather than due to a constitutive lympho-hematopoietic
deﬁciency in the absence of functional Foxp3 protein and Foxp3+
Treg cells. This notion is corroborated bymultiple lines of evidence,
which includes the observation that the BM microenvironment of
Sf and WT mice within the ﬁrst week of life appeared indistin-
guishablewith regard to the capacity to support B cell development
in vivo, as well as the demonstration that early B cell precursors
derived from theBMof moribund Sf mice efﬁciently differentiated
into sIgM+ B cells in vitro. In these experiments, a putative B cell-
intrinsic function of Foxp3 was ﬁrmly excluded using genetic cell
lineage tracing, thus establishing that CD19+ B cells lack Foxp3
expression throughout their entire development and lifespan.
Our temporal analysis of Sf mice during ontogeny has revealed
that both the manifestation of defective B cell development and
the concomitant, although delayed manifestation of T cell devel-
opmental defects closely correlated with progressive autoimmune
pathology. Thus, the apparent discrepancy between previously
reported signiﬁcant residual B lymphopoietic activity in the BM
of 4-week-old Sf mice (Leonardo et al., 2010) and the virtually
complete block of B cell development observed in the present
study is most likely due to variations in the kinetics of autoim-
mune manifestations, perhaps due to differences in the microbial
ﬂora between independent colonies of Foxp3-deﬁcient mice. In
accordance with a dominant role of T cell-mediated autoimmu-
nity, genetic ablation of the Tcra gene revealed the potential of the
BM from adult Sf ×TCRα−/− mice to efﬁciently support B lym-
phopoiesis (Figure 2C),which was found to be sufﬁcient to restore
peripheral compartments of mature B cells, including MZ B and
B-1a cells (Figure 6E).However, these experiments donot formally
exclude the possibility of yet to be identiﬁed B cell developmental
alterations in Sf ×TCRα−/− mice. Exacerbated immune responses
and autoimmune symptoms have been reported to spontaneously
occur in TCRα−/− mice (Mizoguchi et al., 1996).
Clearly, our observation of efﬁcient medullary and
extramedullary B lymphopoiesis early in ontogeny of Sf mice
(Figure 3) provides a plausible explanation for the existence of
a prominent peripheral B cell compartment in adolescent Sf mice,
in the absence of de novo production in the BM. Such a scenario is
corroborated by previous studies in mice with temporally control-
lable deletion of the recombination-activating gene-2 (Hao and
Rajewsky, 2001), demonstrating that, in the absence of inﬂux from
the BM, mature B cells can indeed persist in peripheral lymphoid
organs for several weeks.
Overall, markedly enhanced and prolonged B lymphopoietic
activity in extramedullary sites such as liver and spleen of young
Sf mice may represent an important compensatory mechanism
to alleviate compromised medullary B cell production. Notably,
extramedullary B lymphopoiesis has previously been implicated
in defective negative selection, allowing the survival of develop-
ing self-reactive B cells that would otherwise be deleted during B
cell development in the BM (Sandel et al., 2001). The existence of
self-reactive B cells in Sf mice is evidenced by autoantibodies to a
broad spectrum of self-antigens, including keratin 14 (Huter et al.,
2010), mitochondria (Zhang et al., 2009), glucose-6-phosphate
isomerase (Nguyen et al., 2007), DNA (Leonardo et al., 2010), and
insulin (own unpublished observation). Thus, extramedullary B
lymphopoiesis as a major source of mature B cells in the periphery
of adolescent Sf mice provides a potential mechanism that con-
tributes to the generation of a B cell repertoire that is biased toward
self-antigens, thereby raising the potential for B cell-mediated
autoimmune pathology. Additional studies are warranted to
directly address the relative contributions of extramedullary B
lymphopoiesis and self-reactive B cells to autoimmune pathology
in the absence of functional Foxp3+ Treg cells.
Rather than a mere consequence of impaired HSC function
(Chen et al., 2010), it appears likely thatmultiple and partly redun-
dant autoimmune mechanisms act in concert to mediate aberrant
B lymphopoiesis in Sf mice. Apart from diversion of lymphoid
progenitors from the B lineage in favor of enhanced myelopoiesis
(Lee et al., 2009), additional mechanisms that directly impinge on
B lymphopoiesis in the BM of Sf mice may include the induction
of apoptosis in developing B cells by IFN-γ (Figures 2E,F; and
Grawunder et al., 1993; Garvy and Riley, 1994) and type 1 IFNs
(Figure 2F; Wang et al., 1995), the impairment of developmen-
tal progression to Pre-B cells due to decreased expression of IL-7
(Figure 2G) and the mobilization of lympho-hematopoietic prog-
enitors to the periphery due to decreased expression of CXCL12
(Figure 2G). Indeed, in Foxp3-proﬁcient mice, abolishment of
CXCL12 retention signals in the BM have been reported to result
in a loss of central B lymphopoiesis (Ueda et al., 2004) and reci-
procally increased granulopoiesis (Ueda et al., 2005). In addition,
and consistent with the observation of reduced BM cellularity
(Chen et al., 2010), increasing evidence is pointing toward over-
all alterations in the BM microenvironment of Foxp3-deﬁcient
mice due to aberrations in bone homeostasis owing to exacerbated
osteoclast differentiation and activity (Zaiss et al., 2007, 2010a,b).
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While osteoclasts might be dispensable for HSC maintenance
(Miyamoto et al., 2011), their important function in lympho-
hematopoietic homeostasis was recently highlighted in studies in
an inducible model of osteopetrosis. It was demonstrated that
reduced osteoclast activity results in compromised B lymphopoi-
etic activity by indirect mechanisms, involving a decrease in the
expression of IL-7 and CXCL12 by BM stromal cells (Mansour
et al., 2011).
With regard to extramedullary hematopoiesis, it appears likely
that aberrant B lymphopoiesis in Sf mice arises from both mobi-
lization of lympho-hematopoietic progenitors to spleen and liver
as a consequence of autoimmune-mediated incapacitation of
the BM cavity for hematopoiesis, and from persisting lympho-
hematopoietic progenitor cells at sites of normal fetal and neonatal
hematopoiesis. In contrast, exacerbated production of IL-6 in the
liver of Sf mice (Figure 2F) as potential mechanism to activate
excessive extramedullary hematopoiesis (Peters et al., 1997; Schir-
macher et al., 1998; Tsantikos et al., 2010) appears to play a minor
role, as genetic ablation of IL-6 in Sf × IL-6−/− mice failed to
correct extramedullary B lymphopoiesis (data not shown).
While the impact on lympho-hematopoietic homeostasis had
not been analyzed, previous studies established that neonatal
adoptive transfer of bulk CD4+ T cell populations effectively sup-
presses autoimmunity in Foxp3-deﬁcient recipient mice (Smyk-
Pearson et al., 2003; Chang et al., 2008; Haribhai et al., 2011)
through the concerted action of preformed Foxp3+ Treg cells
and Foxp3+ Treg cells that peripherally converted from initially
Foxp3−CD4+ T cells (Haribhai et al., 2011). Consistently, we
found that, in addition to prolonged survival of Sf recipient mice
(Figure 5A), adoptive Treg cell therapy potently suppressed both
the exacerbated production of T helper (Th) 2 and Th17 cytokines
as well as the manifestation of thymic atrophy and abrogated
T cell developmental activity. Reminiscent of previous observa-
tions under homeostatic conditions in the BM of mice (Lee et al.,
2007, 2009) and humans (Zou et al., 2004), Foxp3GFP+ Treg cells
among adoptively transferred bulk CD4+ T cell populations were
found to be selectively enriched in the BM of Sf recipient mice
(Figure 5C). Interestingly, high-resolution in vivo imaging in an
experimental setting of allogeneic HSC transplantation recently
provided evidence that Foxp3+ Treg cells preferentially accumu-
late in the HSC niche in the BM of non-irradiated recipient mice
and protect HSCs from allogeneic rejection (Fujisaki et al., 2011).
It remains to be determined whether this enrichment of Foxp3+
Treg cells is due to preferential recruitment of preformed cells or
preferential de novo induction from initially CD4+Foxp3− T cells
in the BM microenvironment (Kretschmer et al., 2005, 2006). In
fact, such extrathymic induction of Foxp3+ Treg cells has been
observed in peripheral lymphoid tissues of mice in the steady state
(Schallenberg et al., 2010).
At present, we can only speculate as to why adoptive Treg cell
therapy with bulk CD4+ T cell populations is largely ineffective in
the attenuation of severely aberrant central and peripheral B cell
homeostasis, including a selective failure to suppress exacerbated
Th1 cytokine production and to efﬁciently attenuate BM-derived
expression of IL-7 and CXCL12. Apart from a putative function of
Foxp3 in non-lymphoid BM-derived cells, this observation raises
the interesting possibility that attenuation of individual symp-
toms of autoimmune pathology in Sf mice requires specialized
subsets of Treg cells with distinctly different effector functions
(Chaudhry et al., 2009;Koch et al., 2009; Zheng et al., 2009; Feuerer
et al., 2010). Importantly, increasing evidence for autoimmune-
mediated functional incapacitation of the BM environment in
experimental settings of Foxp3 deﬁciency suggests that transplan-
tation of Foxp3-proﬁcient HSCs prior to the establishment of
permanent autoimmune-mediated damage of the BM niche may
facilitate efﬁcient HSC engraftment. This should improve efﬁcacy
of current therapeutic regimens in human patients with severe
genetic deﬁciencies in functional Foxp3+ Treg cells.
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